Whole genome sequencing offered to breast cancer patients is likely to identify unique genetic features that could either ...

At a median follow-up of 39.4 months, results from the second interim analysis showed a sustained and significant OS benefit with BVd compared to DVd.

Prof David Kerr discusses the new China-UK Cancer Prevention Alliance and how collaboration can transform global cancer ...

Kishan was selected for his pioneering research and leadership in advancing radiation treatments for cancers of the genitourinary system, particularly prostate and bladder cancers.

Non-communicable diseases (NCDs) now account for seven of the world's ten leading causes of death and kill 18 million people ...

Given the potential for volatility in future cancer research and global health funding from the USA due to federal funding cuts, there might be increased strategic value in other countries ...

The updated NCCN guidelines recommend lurbinectedin with atezolizumab for maintenance therapy in ES-SCLC after initial chemoimmunotherapy. The IMforte trial showed a 46% reduction in disease ...

Innovative treatments like JAK2 inhibitors and bispecific antibodies show promise in overcoming immunotherapy resistance in non-small cell lung cancer. Although multiple phase 3 clinical trials have ...

September the 17th, 2025 – The largest private oncology hospital in not only Croatia but in the entire immediate region is set to be constructed in Zagreb. The project is worth a staggering 106 ...

Beyond Efficacy: Cost and Resource Implications of First-Line Systemic Therapies for Metastatic Renal Cell Carcinoma Talquetamab is a G protein–coupled receptor class C group 5 member D ...

Incorporating Continuous Mammographic Density Into the BOADICEA Breast Cancer Risk Prediction Model Cell-free DNA (cfDNA) and matched tumor sample from patients with BTC were analyzed using targeted ...